GENEVA, Aug. 14 -- UNIVERSITY OF MASSACHUSETTS filed a patent application (US2026/013907) for “AAV-BASED SFASL GENE THERAPY FOR THE TREATMENT OF GLAUCOMA”. With publication no. WO/2026/169743, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/705
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....